Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / S&P BIOTECH
-
Number of holders
-
688
-
Total 13F shares, excl. options
-
67,337,299
-
Shares change
-
+7,588,744
-
Total reported value, excl. options
-
$7,540,217,313
-
Value change
-
+$833,516,534
-
Put/Call ratio
-
126%
-
Number of buys
-
289
-
Number of sells
-
-257
-
Price
-
$111.96
Significant Holders of SPDR SERIES TRUST - S&P BIOTECH (XBI) as of Q4 2021
847 filings reported holding XBI - SPDR SERIES TRUST - S&P BIOTECH as of Q4 2021.
SPDR SERIES TRUST - S&P BIOTECH (XBI) has 688 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 67,337,299 shares
.
Largest 10 shareholders include GOLDMAN SACHS GROUP INC (8,083,203 shares), HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND (5,305,000 shares), BANK OF AMERICA CORP /DE/ (4,367,894 shares), CITIGROUP INC (3,640,857 shares), TORONTO DOMINION BANK (3,094,035 shares), MORGAN STANLEY (3,060,040 shares), UBS Group AG (2,555,249 shares), JANE STREET GROUP, LLC (2,508,875 shares), BOXER CAPITAL, LLC (2,200,000 shares), and BARCLAYS PLC (1,938,039 shares).
This table shows the top 688 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.